Home » Topics » BioWorld Science

BioWorld Science
RSS

Sanofi begins phase I/II study of SAR-439483 in LCA caused by GUCY2D mutations

Oct. 16, 2019

Aura updates data from phase Ib/II study of AU-011 in primary choroidal melanoma

Oct. 16, 2019

Principia Biopharma reports preliminary data from phase I/II trial of PRN-1008 in ITP

Oct. 16, 2019

Novavax begins pivotal trial of NanoFlu in older adults

Oct. 16, 2019

[212Pb]Rituximab treatment to overcome hematological toxicity in non-Hodgkin's lymphoma

Oct. 16, 2019

Pfizer identifies muscarinic acetylcholine M4 receptor agonists

Oct. 16, 2019

New eukaryotic translation initiation factor 2B activators patented by Denali Therapeutics

Oct. 16, 2019

Surprise discovery may improve malaria vaccine strategy

Oct. 16, 2019

Medipol University discovers hexokinase-2 inhibitors

Oct. 16, 2019

Kappa-opioid receptor antagonists presented by the University of Kansas, University of Florida

Oct. 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...